Meridian Analytics Rebrands to Discern Health, Focused on Human-Centric Predictive Care
Discern Health’s predictive models allow for life-changing health events to be anticipated so preventative measures can be applied to reduce...
Medicare
Fierce Healthcare Names Lightbeam Health Solutions a “Fierce 15” Company of 2024
Lightbeam earns recognition as a “Fierce 15” Company of 2024, acknowledge for pioneering impact in shaping the future of healthcareDALLAS--(BUSINESS...
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
The decision is further recognition of Eversense as an important option for people with diabetesPARSIPPANY, N.J.--(BUSINESS WIRE)--Ascensia Diabetes Care, a...
McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...
McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on...
Therma Bright’s Venowave Accepted for Review By Center for Medicare & Medicaid Services for Permanent CPT and HCPCS codes
Company To Resume Trading on Toronto Stock Exchange Venture (TSXV) on February 7, 2024Toronto, Ontario--(Newsfile Corp. - February 6, 2024)...
VNAcare and Netsmart Accelerate Hospice Services and Value-Based Care in Southern California
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#HealthcareIT--Netsmart announced an expanded relationship with VNAcare, a non-profit community-based home care agency providing high-quality hospice services...
United States Ambulatory Surgery Center Market Report 2023: Comprehensive Insights Reveal Surge in Hybrid ASC/OBL Models and Technological Innovations – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "2023 United States Ambulatory Surgery Center Market Report" report has been added to ResearchAndMarkets.com's offering. The in-depth analysis...
Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California
The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for...
Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California
The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for...
HCA Healthcare Reports Fourth Quarter 2023 Results and Provides 2024 Guidance
Bill Rutherford to Retire and Mike Marks to Become CFONASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and...
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea...
Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services
WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology...
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and...
Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)
Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) Approval...
Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)
Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared...
MediPines Announces Reimbursement Code for Non-Invasive Assessment of Cardiorespiratory Status by the AGM100
New AMA CPT® Code Establishes Pathway For Clinicians To Submit Claims For Use Of MediPines AGM100®YORBA LINDA, CA / ACCESSWIRE...
New Study Published in Nature Scientific Reports Shows Industry-Leading Performance for Waymark Signal in Predicting Avoidable ER and Hospital Utilization
Peer-reviewed study demonstrates Waymark Signal is 90 percent accurate in predicting avoidable ER and hospital visitsSAN FRANCISCO, CA / ACCESSWIRE...
Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...